Development and Validation of a Machine Learning-Based Model for Predicting the Risk of Unplanned 30-Day Rehospitalization in Patients with Inflammatory Bowel Disease

To develop and validate a machine learning-based predictive model for the risk of unplanned readmission within 30 days among patients with inflammatory bowel disease (IBD), thereby providing a quantitative tool to aid in the early clinical identification of high-risk patients and the optimization of post-discharge management strategies, a multicenter retrospective study design was employed to collect clinical data on inpatients with IBD from three Grade A Level 3 hospitals (the top-tier in mainland China) in Deyang City and Chengdu City of Sichuan Province between October 2021 and October 2024. Using 30-day unplanned readmission as the outcome variable, we employed LASSO regression with five-fold cross-validation to select the optimal predictors and constructed three machine learning prediction models: Support Vector Machine (SVM), XGBoost, and LightGBM. The dataset was randomly split into a training set and a validation set in a 7:3 ratio, and internal validation was performed using the Bootstrap method (2,000 iterations) to compare the accuracy, sensitivity, specificity, and area under the ROC curve (AUC) of the three models. Results demonstrated that a total of 560 IBD patients were enrolled, with 78 cases (13.9%) experiencing unplanned readmission within 30 days. LASSO regression identified seven predictive factors: daily bowel movement frequency, C-reactive protein, albumin, Barthel Index, number of medications prescribed at discharge, regular follow-up, and length of hospital stay. Among the three models, XGBoost performed the best, with an AUC of 0.842 (95% CI: 0.781–0.903) on the validation set, an accuracy of 80.4%, a sensitivity of 76.9%, and a specificity of 81.5%; LightGBM ranked second (AUC = 0.818), while SVM performed the worst (AUC = 0.763). Bootstrap internal validation demonstrated good stability of the XGBoost model (AUC = 0.836, 95% CI: 0.775–0.897). In conclusion, the XGBoost-based risk prediction model for 30-day unplanned readmission in IBD patients exhibits good predictive performance and stability, and could serve as a reference for clinical nursing risk assessment and the formulation of post-discharge follow-up strategies.

Authors

Institutions

Publication Details

Journal
Journal of Biology and Life Science
Published
2026-11-17
DOI
https://doi.org/10.5296/jbls.v18i1.24163
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and Validation of a Machine Learning-Based Model for Predicting the Risk of Unplanned 30-Day Rehospitalization in Patients with Inflammatory Bowel Disease

戴泓, Yao Zeng, Lu Cao
Journal of Biology and Life Science
Inflammatory Bowel Disease
article

Development and Validation of a Machine Learning-Based Model for Predicting the Risk of Unplanned 30-Day Rehospitalization in Patients with Inflammatory Bowel Disease

戴泓, Yao Zeng, Lu Cao
article en

Abstract

To develop and validate a machine learning-based predictive model for the risk of unplanned readmission within 30 days among patients with inflammatory bowel disease (IBD), thereby providing a quantitative tool to aid in the early clinical identification of high-risk patients and the optimization of post-discharge management strategies, a multicenter retrospective study design was employed to collect clinical data on inpatients with IBD from three Grade A Level 3 hospitals (the top-tier in mainland China) in Deyang City and Chengdu City of Sichuan Province between October 2021 and October 2024. Using 30-day unplanned readmission as the outcome variable, we employed LASSO regression with five-fold cross-validation to select the optimal predictors and constructed three machine learning prediction models: Support Vector Machine (SVM), XGBoost, and LightGBM. The dataset was randomly split into a training set and a validation set in a 7:3 ratio, and internal validation was performed using the Bootstrap method (2,000 iterations) to compare the accuracy, sensitivity, specificity, and area under the ROC curve (AUC) of the three models. Results demonstrated that a total of 560 IBD patients were enrolled, with 78 cases (13.9%) experiencing unplanned readmission within 30 days. LASSO regression identified seven predictive factors: daily bowel movement frequency, C-reactive protein, albumin, Barthel Index, number of medications prescribed at discharge, regular follow-up, and length of hospital stay. Among the three models, XGBoost performed the best, with an AUC of 0.842 (95% CI: 0.781–0.903) on the validation set, an accuracy of 80.4%, a sensitivity of 76.9%, and a specificity of 81.5%; LightGBM ranked second (AUC = 0.818), while SVM performed the worst (AUC = 0.763). Bootstrap internal validation demonstrated good stability of the XGBoost model (AUC = 0.836, 95% CI: 0.775–0.897). In conclusion, the XGBoost-based risk prediction model for 30-day unplanned readmission in IBD patients exhibits good predictive performance and stability, and could serve as a reference for clinical nursing risk assessment and the formulation of post-discharge follow-up strategies.

Journal of Biology and Life ScienceVol. 18(1)
Fourth People's Hospital of Sichuan Province (CN), Deyang Stomatological Hospital (CN), Sichuan Provincial Hospital of Traditional Chinese Medicine (CN)
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon